1. Korean society of Obstetrics and Gynecology. Obstetrics 2007;4th ed. Seoul: Koonja Publishing. 193-197.
2. Reddy Uma M., Filly Roy A., Copel Joshua A.. Prenatal Imaging : Ultrasonography and Magnetic Resonance Imaging. American College of Obstetricans and Gynecologists. Obstet Gynecol 2008;112:145-157.
3. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of prenatal ultrasound screening on perinatal outcome. N Engl J Med 1993;329:821-827.
5. Cicero S, Curcio P, Papageorghiou A, Soneck J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11~14 weeks of gestation: an observational study. Lancet 2001;358:1665-1667.
6. Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides K. Maternal serum biochemistry at 11-13+6 weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Prenat Diagn 2005;25:977-983.
7. Pitkin RM. Screening and detection of congenital malformation. Am J Obstet Gynecol 1991;164:1045-1048.
8. Campbell S, Pearce JM. The prenatal diagnosis of fetal structural anomalies by ultrasound. Clin Obstet Gynaecol 1983;10:475-506.
9. Hill LM, Breckle R, Gehrkng WC. Prenatal detection of congenital malformations by ultrasonography. Am J Obstet Gynecol 1985;151:44-50.
10. Manchester DK, Pretorius DH, Avery C, Manco-Johnson ML, Wiggins J, Meier PR, Clewell WH. Accuracy of ultrasound diagnoses in pregnancies complicated by suspected fetal anomalies. Prenat Diagn 1988;8:109-117.
11. Sabbagha RE, Sheikh Z, Tamura RK. Predictive value, sensitivity, and specificity of ultrasonic targeted imaging for fetal anomalies in gravid women at high risk for birth defects. Am J Obstet Gynecol 1985;152:822-827.
12. Filly RA, Cardorza JD, Goldstein RB, Barkovich AJ. Detection of fetal central nervous system anomalies: A practical level of effort for a routine sonogram. Radiology 1989;172:309-311.
13. Yeo L, Vintzileos AM. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome. Semin perinatol 2003;27:152-159.
14. Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 1995;17:1639-1640.
15. Benacerraf BR, Nadel AS, Bromley B. Identification of second trimester fetuses with autosomal trisomy by use of a sonographic scoring index. Radiology 1994;193:135-140.
16. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: Description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998;12:8-14.
17. Wax JR, Guilbert J, Mather J, Chen C, Royer D, Steinfeld JD, Ingardia CJ. Efficacy of community-based second trimester genetic ultrasonography in detecting the chromosomally abnormal fetus. J Ultrasound med 2000;19:689-694.
18. Gonçalves LF, Lee W, Espinoza J, Romero R. Three- and 4-dimensional ultrasound in obstetric practice: does it help? J Ultrasound Med 2005;24:1599-1624.
19. Gonçalve LF, Nien JK, Espinoza J, Kusanovic JP, Lee W, Swope B, Soto E, Treadwell MC, Romero R. What does 2-dimensional imaging add to 3-and 4-dimensional obstetric ultrasonography? J Ultrasound Med 2006;25:691-699.
20. Levine D, Barens PD, Madsen JR, Li W, Edelman RR. Fetal central nervous system anomalies: MR imaging augments sonographic diagnosis. Radiology 1997;204:635-642.
21. Sponcer K, Spencer CE, Power M, Dawson C, Nicoladies KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum bioche-mistry in a one-step clinic: a review three years prospec-tive experience. BJOG 2003;110:281-286.
22. Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 1992;12:801-806.
23. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996;16:143-153.
24. Malone Fergal D, Wald Nicholas J, Canick Jacob A, Ball Robert H, Nybergl David A. First- and second-trimester evaluation of risk (faster): trial principal results of the NICHD multicenter Down syndrome screening study. Am J of Obstet Gynecol 2003;189:S. 79.
25. Biggio JR, Morris TC, Owen J, Stringer JSA. An outcome analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Am J of Obstet Gynecol 2004;190:721-729.